In an effort to limit shortages multiple states are already making the criteria for prescription even more limited (anyone who prescribed it for COVID-19 was already making an off-label prescription):
https://www.reuters.com/article/us-health-coronavirus-usa-ph...
Also of note, the couple took `chloroquine phosphate` not `hydroxychloroquine` which was what the government just fast-tracked and is apparently a 3x more effective treatment than the former. According to Wikipedia, HCQ is used for people sensitive to Chloroquine-phospate:
> Specifically it is used for chloroquine-sensitive malaria
https://en.wikipedia.org/wiki/Hydroxychloroquine
We don't yet know if the person in the article was prescribed it or even had any symptoms/prior medical history.
HCQ is used for Malaria that is chloroquine sensitive, not people. Well that’s how I read it.
Looks like it was patented in 2005, which might also help explain why it became more common? But I”m totally guessing that: https://en.wikipedia.org/wiki/4-Aminoquinoline
Yep there's some chloroquine phosphate resistant malaria (Plasmodium) that hydroxychloroquine still works for. It also works for the other non-resistant ones making it a good first option, more here:
https://www.drugs.com/monograph/hydroxychloroquine-sulfate.h...
There's no current patent on either drugs. But as I said, data was showing HCQ was 3x more effective, which was why the new studies are focusing on that...